IL6 and endothelial dysfunction: This phenomenon of ergothioneine could effectively regulate endovascular inflammation caused by endothelial dysfunction and reduce the release of pro-inflammatory factors, including interleukin-6 (IL-6), IL-1β, and TNF-α (Lam-Sidun et al., 2021).